Rigel Pharmaceuticals (RIGL)

$41.94 +2.06 (5.17%)
Market Cap 723.86M
Revenue (ttm) 179.28M
Net Income (ttm) 17.49M
EPS (ttm) N/A
PE Ratio 6.47
Forward PE 6.41
Profit Margin 9.76%
Debt to Equity Ratio 0.25
Volume 714,200
Avg Vol 646,962
Day's Range N/A - N/A
Shares Out 18.15M
Stochastic %K 96%
Beta 1.22
Analysts Strong Sell
Price Target $46.20

Company Profile

Rigel Pharmaceuticals, Inc., a biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer. The company's commercialized products include Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia; Rezlidhia, a non-intensive monotherapy to treat adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a suscept...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 624 1100
Fax: 650 624 1101
Address:
611 Gateway Boulevard, Suite 900, South San Francisco, United States
Gabriel1234
Gabriel1234 Nov. 14 at 10:38 PM
$RIGL
0 · Reply
amunka
amunka Nov. 14 at 9:18 PM
$RIGL opened a starter position here with 500 shares. Wish me luck!
0 · Reply
liloleme4
liloleme4 Nov. 14 at 9:14 PM
$RIGL Had a good day today with my portfolio overall, but really liked seeing RIGL keep moving forward. Unfortunately they're only 5th in my $$ invested, but it still looks nice seeing them at >100% profit and knowing there are likely more to be added in the future
0 · Reply
Namhguab
Namhguab Nov. 14 at 8:52 PM
$RIGL I would not want to be short for any Monday at this point. Merger Monday’s are real.
1 · Reply
elitechrisvp
elitechrisvp Nov. 14 at 8:45 PM
$RIGL sweet baby Jesus
0 · Reply
B4I4QQTRU18
B4I4QQTRU18 Nov. 14 at 8:41 PM
$RIGL Hey shorts, remember when you drop the price right before earnings. I bought an extra 500 shares. They are up for sale until close today for 43.25. Monday they will be 46.25.
1 · Reply
Berakhot
Berakhot Nov. 14 at 8:27 PM
$RIGL Monthly Chart All-time looks interesting. Break 43's and may break Shorts for a squeeze. Top out is 50s for RIGL in the past. Back when they were in the hole deep and had little Rev to rely on June 2021.
0 · Reply
Stock_Savage
Stock_Savage Nov. 14 at 8:21 PM
$RIGL This will never be “trending” but that’s fine with me.
0 · Reply
Berakhot
Berakhot Nov. 14 at 7:41 PM
$RIGL oooooooohhhhoooo flagging... come on 50s.
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 6:11 PM
Hedge Alert Live - Protect Your Portfolio Contract: $RIGL $41.00 Put · NOV 21, 2025 Exp Entry Price: $4.45 - $4.90 Exit Price Target: $7.08 Profit Margin: +59% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Latest News on RIGL
Rigel to Present at the Jefferies Global Healthcare Conference in London

Nov 12, 2025, 8:05 AM EST - 2 days ago

Rigel to Present at the Jefferies Global Healthcare Conference in London

Rigel Pharmaceuticals, Inc. (RIGL) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 8:06 PM EST - 10 days ago

Rigel Pharmaceuticals, Inc. (RIGL) Q3 2025 Earnings Call Transcript

Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 4, 2025, 4:01 PM EST - 10 days ago

Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update

Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition

Nov 3, 2025, 9:05 AM EST - 11 days ago

Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition

This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is 'growing substantially'

Oct 30, 2025, 2:20 PM EDT - 15 days ago

This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is 'growing substantially'

Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update

Oct 29, 2025, 8:05 AM EDT - 16 days ago

Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update

Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS

Oct 8, 2025, 8:05 AM EDT - 5 weeks ago

Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Oct 3, 2025, 8:05 AM EDT - 6 weeks ago

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion

Sep 25, 2025, 10:53 PM EDT - 7 weeks ago

Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion

Rigel to Participate in Upcoming September Investor Conferences

Aug 26, 2025, 8:05 AM EDT - 2 months ago

Rigel to Participate in Upcoming September Investor Conferences

Overlooked Stock: RIGL Nearly Doubles Stock in August

Aug 15, 2025, 5:20 PM EDT - 3 months ago

Overlooked Stock: RIGL Nearly Doubles Stock in August

The Big 3: OPEN, RIGL, JOBY

Aug 15, 2025, 12:00 PM EDT - 3 months ago

The Big 3: OPEN, RIGL, JOBY

JOBY OPEN

Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout

Aug 13, 2025, 11:58 PM EDT - 3 months ago

Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout

Rigel Pharmaceuticals, Inc. (RIGL) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 8:02 PM EDT - 3 months ago

Rigel Pharmaceuticals, Inc. (RIGL) Q2 2025 Earnings Call Transcript

Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 5, 2025, 4:01 PM EDT - 3 months ago

Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update

Rigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and Business Update

Jul 29, 2025, 8:05 AM EDT - 3 months ago

Rigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and Business Update

Rigel to Present at the Jefferies Global Healthcare Conference

May 28, 2025, 8:05 AM EDT - 6 months ago

Rigel to Present at the Jefferies Global Healthcare Conference

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress

May 22, 2025, 5:20 PM EDT - 6 months ago

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress

Rigel Pharmaceuticals: Q1 Earnings Showcase Growing Momentum

May 7, 2025, 6:16 PM EDT - 6 months ago

Rigel Pharmaceuticals: Q1 Earnings Showcase Growing Momentum

Rigel Pharmaceuticals, Inc. (RIGL) Q1 2025 Earnings Call Transcript

May 6, 2025, 11:13 PM EDT - 6 months ago

Rigel Pharmaceuticals, Inc. (RIGL) Q1 2025 Earnings Call Transcript

Rigel Reports First Quarter 2025 Financial Results and Provides Business Update

May 6, 2025, 4:01 PM EDT - 6 months ago

Rigel Reports First Quarter 2025 Financial Results and Provides Business Update

Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update

Apr 29, 2025, 8:05 AM EDT - 7 months ago

Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update

Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability

Apr 4, 2025, 3:31 PM EDT - 8 months ago

Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability

Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Patent Litigation

Mar 27, 2025, 8:05 AM EDT - 8 months ago

Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Patent Litigation

Rigel Appoints Mark W. Frohlich, M.D.

Mar 10, 2025, 8:05 AM EDT - 8 months ago

Rigel Appoints Mark W. Frohlich, M.D.

Rigel Pharmaceuticals, Inc. (RIGL) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 11:29 PM EST - 9 months ago

Rigel Pharmaceuticals, Inc. (RIGL) Q4 2024 Earnings Call Transcript

Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 4, 2025, 4:01 PM EST - 9 months ago

Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update

Feb 25, 2025, 8:05 AM EST - 9 months ago

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update

Rigel's Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease

Jan 22, 2025, 8:05 AM EST - 10 months ago

Rigel's Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease

Rigel Provides Business Update and 2025 Outlook

Jan 13, 2025, 8:05 AM EST - 10 months ago

Rigel Provides Business Update and 2025 Outlook

Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS

Jan 9, 2025, 8:05 AM EST - 11 months ago

Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS

Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 8, 2025, 8:05 AM EST - 11 months ago

Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Rigel Pharmaceuticals: Realizing The Promise Of Its Acquired Pipeline Agents

Dec 30, 2024, 8:30 AM EST - 11 months ago

Rigel Pharmaceuticals: Realizing The Promise Of Its Acquired Pipeline Agents

Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition

Dec 9, 2024, 12:02 PM EST - 1 year ago

Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition

Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS

Dec 2, 2024, 8:05 AM EST - 1 year ago

Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS

Rigel to Present at the Jefferies London Healthcare Conference

Nov 12, 2024, 8:05 AM EST - 1 year ago

Rigel to Present at the Jefferies London Healthcare Conference

Rigel Pharmaceuticals, Inc. (RIGL) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 10:25 PM EST - 1 year ago

Rigel Pharmaceuticals, Inc. (RIGL) Q3 2024 Earnings Call Transcript

Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 7, 2024, 4:01 PM EST - 1 year ago

Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update

Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and Exposition

Nov 5, 2024, 9:05 AM EST - 1 year ago

Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and Exposition

Rigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Business Update

Oct 31, 2024, 8:05 AM EDT - 1 year ago

Rigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Business Update

Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO® (pralsetinib)

Oct 24, 2024, 4:35 PM EDT - 1 year ago

Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO® (pralsetinib)

Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®

Oct 16, 2024, 10:00 AM EDT - 1 year ago

Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®

Rigel Pharmaceuticals: Looking For More Growth

Oct 10, 2024, 7:32 AM EDT - 1 year ago

Rigel Pharmaceuticals: Looking For More Growth

Rigel Pharma Remains Bullish, Growth Fueled By FDA-Approved Drugs, Strategic Partnerships

Oct 9, 2024, 8:42 PM EDT - 1 year ago

Rigel Pharma Remains Bullish, Growth Fueled By FDA-Approved Drugs, Strategic Partnerships

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Oct 4, 2024, 8:05 AM EDT - 1 year ago

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Rigel to Present at the 2024 Cantor Global Healthcare Conference

Sep 12, 2024, 8:05 AM EDT - 1 year ago

Rigel to Present at the 2024 Cantor Global Healthcare Conference

Rigel Announces First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA® (olutasidenib) in mIDH1 AML

Sep 5, 2024, 7:30 AM EDT - 1 year ago

Rigel Announces First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA® (olutasidenib) in mIDH1 AML

Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republic of Korea and Taiwan

Sep 3, 2024, 8:00 AM EDT - 1 year ago

Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republic of Korea and Taiwan

Rigel Pharmaceuticals, Inc. (RIGL) Q2 2024 Earnings Call Transcript

Aug 9, 2024, 2:12 PM EDT - 1 year ago

Rigel Pharmaceuticals, Inc. (RIGL) Q2 2024 Earnings Call Transcript

Rigel Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 6, 2024, 4:01 PM EDT - 1 year ago

Rigel Reports Second Quarter 2024 Financial Results and Provides Business Update

Gabriel1234
Gabriel1234 Nov. 14 at 10:38 PM
$RIGL
0 · Reply
amunka
amunka Nov. 14 at 9:18 PM
$RIGL opened a starter position here with 500 shares. Wish me luck!
0 · Reply
liloleme4
liloleme4 Nov. 14 at 9:14 PM
$RIGL Had a good day today with my portfolio overall, but really liked seeing RIGL keep moving forward. Unfortunately they're only 5th in my $$ invested, but it still looks nice seeing them at >100% profit and knowing there are likely more to be added in the future
0 · Reply
Namhguab
Namhguab Nov. 14 at 8:52 PM
$RIGL I would not want to be short for any Monday at this point. Merger Monday’s are real.
1 · Reply
elitechrisvp
elitechrisvp Nov. 14 at 8:45 PM
$RIGL sweet baby Jesus
0 · Reply
B4I4QQTRU18
B4I4QQTRU18 Nov. 14 at 8:41 PM
$RIGL Hey shorts, remember when you drop the price right before earnings. I bought an extra 500 shares. They are up for sale until close today for 43.25. Monday they will be 46.25.
1 · Reply
Berakhot
Berakhot Nov. 14 at 8:27 PM
$RIGL Monthly Chart All-time looks interesting. Break 43's and may break Shorts for a squeeze. Top out is 50s for RIGL in the past. Back when they were in the hole deep and had little Rev to rely on June 2021.
0 · Reply
Stock_Savage
Stock_Savage Nov. 14 at 8:21 PM
$RIGL This will never be “trending” but that’s fine with me.
0 · Reply
Berakhot
Berakhot Nov. 14 at 7:41 PM
$RIGL oooooooohhhhoooo flagging... come on 50s.
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 6:11 PM
Hedge Alert Live - Protect Your Portfolio Contract: $RIGL $41.00 Put · NOV 21, 2025 Exp Entry Price: $4.45 - $4.90 Exit Price Target: $7.08 Profit Margin: +59% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 14 at 5:47 PM
💎 LiquidTheta® Live Actionable Trade Asset: $RIGL Contracts: $RIGL June 18, 2026 $40 Calls Scale in: $8.03- $9.82 Scale out: $31.24-$53.55 Profit Potential : 368% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
elitechrisvp
elitechrisvp Nov. 14 at 5:42 PM
$XBI power ✅️$IBRX $RIGL
0 · Reply
MaxKlim
MaxKlim Nov. 14 at 5:16 PM
$RIGL https://fintel.io/so/us/rigl
0 · Reply
FV_Trader
FV_Trader Nov. 14 at 5:04 PM
$RIGL 44+ EOD
0 · Reply
B4I4QQTRU18
B4I4QQTRU18 Nov. 14 at 4:57 PM
$RIGL
0 · Reply
GuyGuyGuyGuyGuy
GuyGuyGuyGuyGuy Nov. 14 at 4:28 PM
$RIGL Next week 50+? 🤨
1 · Reply
nirok
nirok Nov. 14 at 4:02 PM
$RIGL Don’t forget about the conference on December 7 gotta be positive. They wouldn’t do it if wasn’t positive, It feels to me that Lily is going to make an offer soon they’re not gonna wait until price will be much much higher, even though they have lots of cash on hand
3 · Reply
moneybag888
moneybag888 Nov. 14 at 3:33 PM
$RIGL $ARGX $REGN
0 · Reply
nirok
nirok Nov. 14 at 3:11 PM
$RIGL Lly and Rigal are going up in the same time for the last week and for Lily to throw a few billion dollars for regular it’s nothing ,they just gained about $250 billion in market cap
0 · Reply
nirok
nirok Nov. 14 at 3:11 PM
$RIGL This company is a cash machine generating almost $30,000,000 a quarter
0 · Reply
nirok
nirok Nov. 14 at 3:11 PM
$RIGL We are just a good company in a great sector with a eps over six dollars, and still a very undervalued
0 · Reply
mitgodog
mitgodog Nov. 14 at 3:04 PM
$RIGL Well, I was expecting a red day with the way the markets are looking. Will not complain one bit😁
1 · Reply